Found: 3
Select item for more details and to access through your institution.
Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study.
- Published in:
- Infezioni in Medicina, 2021, v. 29, n. 1, p. 102
- By:
- Publication type:
- Article
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens.
- Published in:
- Open Medicine, 2021, v. 16, n. 1, p. 672, doi. 10.1515/med-2021-0274
- By:
- Publication type:
- Article
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab‐based regimens.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 14, p. 1, doi. 10.1002/cam4.7402
- By:
- Publication type:
- Article